Who
Stanley Frankel
Director
Company insider
Files Form 4 as: Director, Precision BioSciences.
In numbers
- Trades disclosed
- 19
- Buys
- 3
- Sells
- 0
- Bought
- $38K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 12 Apr 2021
- Last trade
- 28 Sep 2026
- Last filed
- 30 Sep 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Sep 2026filed 30 Sep 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $6,0001,000 at $6.00 | filing |
| 28 Sep 2026filed 30 Sep 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $6,0001,000 at $6.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,979 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,979 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —21,000 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —21,000 | filing |
| 16 Dec 2025filed 17 Dec 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $13K2,700 at $4.70 | filing |
| 26 Sep 2025filed 30 Sep 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $13K2,700 at $4.97 | filing |
| 3 Jun 2025filed 4 Jun 2025 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 27 May 2025filed 4 Jun 2025 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,826 at $0.00 | filing |
| 27 May 2025filed 4 Jun 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —9,826 | filing |
| 4 Jun 2024filed 6 Jun 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,826 at $0.00 | filing |
| 4 May 2024filed 7 May 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,202 at $0.00 | filing |
| 4 May 2024filed 7 May 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —4,202 | filing |
| 4 May 2023filed 8 May 2023 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —126,075 at $0.00 | filing |
| 10 May 2022filed 12 May 2022 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —156,951 at $0.00 | filing |
| 12 Apr 2021filed 14 Apr 2021 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,325 at $0.00 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Stanley Frankel; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.